Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Neurotidine® (Citicoline Free Acid in Oral Solution) on Quality of Life in Patients With Glaucoma

NCT04046809 is registered in ClinicalTrials.gov with Omikron Italia S.r.l. as lead sponsor.

NCT NCT04046809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04046809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Neurotidine® (Citicoline Free Acid in Oral Solution) on Quality of Life in Patients With Glaucoma
Lead sponsor
Omikron Italia S.r.l.
Phase
Not applicable
Overall status
Completed
Start date
February 13, 2019
Completion date
January 24, 2022
Enrollment
155 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma